A public choice framework for controlling transmissible and evolving diseases
暂无分享,去创建一个
Carl T. Bergstrom | Carl T Bergstrom | T. Bergstrom | B. Althouse | Benjamin M Althouse | Theodore C Bergstrom
[1] Paul A. Samuelson,et al. Diagrammatic Exposition of a Theory of Public Expenditure , 1955 .
[2] Franz J. Weissing,et al. Self-Interest versus Group-Interest in Antiviral Control , 2008, PloS one.
[3] R. Duncan,et al. Diagnosis and Management of Acute Otitis Media , 2019, Jurnal Penelitian Perawat Profesional.
[4] Raffaele Vardavas,et al. Can Influenza Epidemics Be Prevented by Voluntary Vaccination? , 2007, PLoS Comput. Biol..
[5] The economic control of infectious diseases , 2001 .
[6] J. Medlock,et al. Optimizing Influenza Vaccine Distribution , 2009, Science.
[7] Mark Gersovitz,et al. Infectious Diseases, Public Policy, and the Marriage of Economics and Epidemiology , 2003 .
[8] Timothy C. Reluga,et al. Evolving public perceptions and stability in vaccine uptake. , 2006, Mathematical biosciences.
[9] M. Keeling,et al. Modeling Infectious Diseases in Humans and Animals , 2007 .
[10] P. Geoffard,et al. Disease Eradication: Private versus Public Vaccination , 1997 .
[11] S Bonhoeffer,et al. Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] B. Levin,et al. Antiviral Resistance and the Control of Pandemic Influenza , 2007, PLoS medicine.
[13] D. Earn,et al. Group interest versus self-interest in smallpox vaccination policy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] G. Zuccotti,et al. The evolution of influenza resistance and treatment. , 2009, JAMA.
[15] H. Grundmann,et al. Do We Need to Put Society First? The Potential for Tragedy in Antimicrobial Resistance , 2006, PLoS medicine.
[16] M. Lipsitch,et al. Antimicrobial Use and Antimicrobial Resistance: A Population Perspective , 2002, Emerging Infectious Diseases.
[17] P. Francis. Dynamic epidemiology and the market for vaccinations , 1997 .
[18] T. Philipson,et al. Private Vaccination and Public Health: An Empirical Examination for U.S. Measles , 1996 .
[19] M. Intriligator,et al. Externalities and compulsary vaccinations , 1991 .
[20] Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP). , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[21] Mark Gersovitz,et al. The Economical Control of Infectious Diseases , 2000 .
[22] P. Fine,et al. Individual versus public priorities in the determination of optimal vaccination policies. , 1986, American journal of epidemiology.
[23] J. Hughes,et al. Trends in antimicrobial prescribing rates for children and adolescents. , 2002, JAMA.
[24] Timothy C. Reluga,et al. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum , 2007, Proceedings of the National Academy of Sciences.
[25] M. Lipsitch,et al. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] David L. Smith,et al. Strategic interactions in multi-institutional epidemics of antibiotic resistance. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] I. Longini,et al. What is the best control strategy for multiple infectious disease outbreaks? , 2007, Proceedings of the Royal Society B: Biological Sciences.
[28] P. Samuelson. The Pure Theory of Public Expanditure , 1954 .
[29] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[30] Carl T. Bergstrom,et al. The ecology and evolution of antibiotic-resistant bacteria , 2007 .
[31] M. Jeuland,et al. Using private demand studies to calculate socially optimal vaccine subsidies in developing countries. , 2009, Journal of policy analysis and management : [the journal of the Association for Public Policy Analysis and Management].
[32] A. Read,et al. Pathogen evolution in a vaccinated world , 2010 .
[33] Mark Gersovitz,et al. Tax/subsidy policies toward vector-borne infectious diseases , 2005 .
[34] D. Earn,et al. Vaccination and the theory of games. , 2004, Proceedings of the National Academy of Sciences of the United States of America.